Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-058277
Filing Date
2021-04-30
Accepted
2021-04-30 08:31:45
Documents
6
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2113618-1_def14a.htm DEF 14A 671276
2 GRAPHIC lg_eyenovia-4clr.jpg GRAPHIC 53894
3 GRAPHIC tm2113618d1-icon_chairbw.jpg GRAPHIC 758
4 GRAPHIC tm2113618d1-icon_memberbw.jpg GRAPHIC 690
5 GRAPHIC tm2113618d1-proxy_3eyebw.jpg GRAPHIC 549268
6 GRAPHIC tm2113618d1-proxy_4eyebw.jpg GRAPHIC 422153
  Complete submission text file 0001104659-21-058277.txt   2087059
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38365 | Film No.: 21873914
SIC: 2834 Pharmaceutical Preparations